Tilmann Steinmetz

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

Beate Schultheis, Dirk Reuter, M. Ebert et al. · Annals of Oncology · 2017 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Assessment of human immediate response capability related to tsunami threats in Indonesia at a sub-national scale

Joachim Post, Stephanie Wegscheider, Matthias Mück et al. · Natural hazards and earth system sciences · 2009 · 91 citations · Full text

Planning, Emergency Planning, Disaster Response +12

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

Stefan Boeck, K. Weigang-Köhler, Martin Fuchs et al. · Annals of Oncology · 2007 · 68 citations · Full text

Medicine, Oncology, Pharmacology +9

Toxoplasma gondii-induced foetal resorption in mice involves interferon-γ-induced apoptosis and spiral artery dilation at the maternofoetal interface

Alexandre Senegas, Odile Villard, A. Neuville et al. · International Journal for Parasitology · 2008 · 63 citations

Life Sciences, Cell Biology, Immunology +9

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

Meinolf Karthaus, Harald Balló, W. Abenhardt et al. · Oncology · 2005 · 49 citations

Medicine, Oncology, Pharmacotherapy +17